Gaël Hédou
Founder en Sonnet BioTherapeutics CH SA .
Perfil
Gaël Hédou has founded Sonnet BioTherapeutics CH SA in 2013, where he holds the title of Director.
He was the Chief Executive & Operating Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019.
Dr. Hédou holds a doctorate from the Swiss Federal Institute of Technology and an undergraduate degree from the University of Strasbourg, which he received in 1997.
Cargos activos de Gaël Hédou
| Empresas | Cargo | Inicio |
|---|---|---|
Sonnet BioTherapeutics CH SA
 Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Founder | 01/01/2013 |
Antiguos cargos conocidos de Gaël Hédou.
| Empresas | Cargo | Fin |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Chief Executive Officer | 30/06/2019 |
Formación de Gaël Hédou.
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of Strasbourg | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Gaël Hédou
